icon- folder.gif   Conference Reports for NATAP  
 
  Fatty Liver Disease

  
 
 
 
NASH Globally - Pathways to combination therapies, biomarkers and outcomes
 
 
  Arun Sanyal, MD
 
HepDart Dec 3-7 2017 Hawaii

1211171

1211172

1211173

1211174

1211175

1211176

1211177

1211178

1211179

12111710

12111711

12111712

12111713

12111714

AASLD: Prevalence and Clinical Characteristics of Nonalcoholic Fatty Liver Disease in Lean Subjects in Comparison with Overweight or Obese Individuals: A cross-sectional study - (11/20/17)

12111715

12111716

12111717

12111718

12111719

12111720

12111721

12111722

12111723

12111724